Thomas Eldered

Thomas Eldered General Information

Description

Mr. Thomas Eldered is the Founder & serves as Executive Chairman of the Board at Flerie. He also serves as Chairman of the Supervisory Board at Amarna Therapeutics. He serves as Executive Chairman at Frontier Biosolutions. He served as President and Chief Executive Officer at Recipharm. He serves as Chairman at Prokarium. He served as Chairman at Cobra Biologics. He also serves as President at Fleurie Invest. He served as a Board Member at Empros Pharma. He was the Vice President of Recip AB from 1995-2007 and a factory manager at Pharmacia from 1990-1995. He is also the Chairman of the board of B&E Participation, Cobra Biologics Holding AB, and Trimeta LLC, B&E Participation. He currently is a board member of Buzzard Pharmaceuticals, Flerie Participation AB, Pingvinen Penningplacering Aktiebolag, SwedenBIO Service AB, Sweden Bio, B&E Invest AB, Chromafora AB, Zentricity International AB, Flerie Invest AB, Kahr Medical Ltd, and Provell Pharmaceutical LLC. He holds an M.Sc. in Industrial and Management Engineering from the Linköping Institute of Technology in 1985. Based in Stockholm and London and with investments across the EU, UK, US, and Israel, the beginnings of Flerie Invest started with him, co-founder and builder of Recipharm, which within 25 years became the fifth largest pharma CDMO in the world